MappBio Collaborates with Aridis Pharmaceuticals to Develop Therapies Utilizing APEX Technology

 MappBio Collaborates with Aridis Pharmaceuticals to Develop Therapies Utilizing APEX Technology

MappBio Collaborates with Aridis Pharmaceuticals to Develop Therapies Utilizing APEX Technology

Shots:

  • MappBio collaborates with Aridis Pharmaceuticals to develop mAbs productivity enhanced versions of CHO cell lines utilizing Aridis’s APEX Technology
  • CHO cell lines are developed from Chinese hamster ovary. The CHO cell line are developed by MappBio
  • APEX technology is a mAb discovery platform that enables the screening and single cell cloning of antibody producing B-cells using microarrays and is built upon Aridis’ hybridoma-based technology platform, MabIgX allowing rapid fusion and production of mAbs directly from patients antibody-producing B-cells

Click here to read full press release/ article | Ref: Aridis Pharmaceuticals | Image: Twitter

Shiwani Sharma

Shiwani Sharma is a Senior Editor at PharmaShots. She has in-depth knowledge of lifesciences industry including pharma and biotech sectors. She also covers news in field of Digital Health, Medtech and regulatory approvals from the US FDA, EU, and other global regulatory bodies in the industry. Additionally, she also writes Whitepapers, analysis reports, blogs on pharma and biotech industry. She is graduate in Biotechnology. She can be contacted on shiwani@pharmashots.com

Related post